Director, Chief Operating Officer · BioAge Labs, Inc. · BioAge Labs, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
12.5K
Price
—
Executed
Feb 17, 2026
Disclosed
Feb 19, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 17 executedFeb 19, 2026 disclosed
BIOA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Morgen Eric filed this Form 4 reporting a grant or award of BIOA on Feb 17, 2026. It became public on Feb 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Operating Officer
Morgen Ericcik:0002036289
Issuer
BioAge Labs, Inc.cik:0001709941
Revision history · 0
No field has changed since this record was first ingested.
